John Boslego, MD

Global Program Leader, Vaccine Development

Dr. Boslego directs PATH’s vaccine development program, which seeks to identify and facilitate the development of safe, effective, affordable vaccines against select major disease threats in the developing world.

Dr. Boslego’s career spans 30 years of service to private industry and the United States government. Before joining PATH, he served as executive director of Biologics, Clinical Research, at Merck & Co., Inc. His portfolio at Merck included clinical development of a Haemophilus influenzae type b conjugate vaccine, a recombinant hepatitis B vaccine, an influenza DNA vaccine, a pneumococcal polysaccharide vaccine, a pneumococcal conjugate vaccine, various pediatric combination vaccines, a rotavirus vaccine, and a human papillomavirus vaccine.

For nearly two decades, Dr. Boslego worked for the Walter Reed Army Institute of Research in vaccine research—both in the laboratory and in clinical trials. He also directed the Armed Forces Research Institute of Medical Sciences in Thailand for three years.

Dr. Boslego received his medical education at George Washington University after graduating from the United States Military Academy.

Michael J. Free, PhD, OBE

Senior Advisor Emeritus

Dr. Free serves as PATH’s senior advisor emeritus. In this role, he offers guidance to senior leadership on issues from research and development to technology transfer, licensing, marketing, quality assessment, and introduction. Previously, as PATH’s vice president and senior advisor for technologies, Dr. Free oversaw PATH’s technology development; was the global program leader for Technology Solutions; and directed the Technologies for Health Program (HealthTech), funded by the US Agency for International Development, and the Health Innovation Portfolio, funded by individual contributors and the Bill & Melinda Gates Foundation.

Dr. Free was instrumental in PATH’s inception in 1977 and in establishing PATH’s biotechnology laboratory and product design and development facilities. He led more than 100 staff working on a range of health technology projects addressing the specific health care needs of resource-poor populations. Under Dr. Free’s leadership, PATH advanced more than 80 technologies, many of which are currently being manufactured, sold, and used in developing countries.

Dr. Free has more than 40 years of research and development experience in health technology, including eight years at Battelle Northwest, where he developed technologies to improve reproductive health. He holds four patents, and among his extensive publications in research, technology, family planning, and health issues are 15 invited book chapters and symposium reviews.

He received his bachelor of science degree in physiology from University of Nottingham, England, and his master of science and doctorate in physiology from Ohio State University in Columbus. In 2011, Dr. Free was named an Officer of the Order of the British Empire (OBE) in recognition of his achievements in improving global health and his dedication to increasing the availability of health technologies designed for resource-poor settings.

Jane Hutchings, MPH

Global Program Leader, Reproductive Health

Jane Hutchings directs PATH’s work in reproductive health, providing strategic and managerial guidance as well as technical expertise. She has more than 25 years of experience in designing and implementing innovative and effective reproductive health programs in developing countries, including Bangladesh, Cambodia, Guatemala, India, Kenya, Nicaragua, Pakistan, Thailand, Ukraine, Vietnam, and the United States.

Ms. Hutchings has developed multiple successful collaborative efforts within the United States and internationally to strengthen reproductive health programs, whole-market approaches, and access to low-cost, high-quality products. She managed a six-year, multicountry project to strengthen pharmacists' skills and understanding of critical reproductive health issues and continues to serve as a strategist and technical advisor for PATH's pharmacy-focused work.

In addition, Ms. Hutchings has done extensive work with emergency contraception, including serving on the International Consortium for Emergency Contraception steering committee and working within Washington State in the first US effort for direct pharmacist provision of emergency contraception. She led the development of the Reproductive Health Supplies Coalition and currently oversees PATH's participation as secretariat and partner. Ms. Hutchings also leads PATH's efforts in reproductive health supplies security and directs our collaboration with the World Health Organization to ensure access to essential reproductive health medicines and devices.

Before joining PATH in 1983, Ms. Hutchings worked in Japan and served as a Peace Corps volunteer in Malaysia. She attended the University of Michigan, where she received an MPH with an emphasis on international population planning policy and program development.

David C. Kaslow, MD

Global Program Leader, Malaria Vaccine Initiative

Dr. Kaslow directs the PATH Malaria Vaccine Initiative (MVI), which works to accelerate the development of malaria vaccines and ensure they are available and accessible for the developing world. He has more than 25 years of experience in vaccine research and development.

Before joining PATH, Dr. Kaslow held key advisory positions with MVI and the Bill & Melinda Gates Foundation related to malaria vaccines. He previously oversaw project leadership and management of Merck Research Laboratories’ vaccine pipeline and founded the Malaria Vaccine Development Unit at the National Institutes of Health.

As a basic research scientist, Dr. Kaslow completed the molecular cloning and characterization of several proteins involved in malaria parasite sexual development. He also has directed product development, including field studies, of several malaria vaccine candidates. Outside the malaria field, Dr. Kaslow has contributed to the vaccine application of tools originally developed for gene therapy. He holds or co-holds more than a dozen patents and has published more than 150 scientific papers.

Dr. Kaslow received his medical degree from the University of California, San Francisco.

Anurag Mairal, PhD

Global Program Leader, Technology Solutions

Dr. Mairal oversees PATH’s research and development, commercialization, and implementation of technologies to improve health. Particular areas of focus include maternal and neonatal health, nutrition, water and sanitation, health management information systems, reproductive health, vaccine-related technologies, and diagnostics for infectious and noncommunicable diseases.

Dr. Mairal has an extensive background in medical device development, collaborating with partners in India, China, and other countries to advance product development, manufacturing, and distribution. Prior to joining PATH in 2013, Dr. Mairal served as consulting assistant professor at the Stanford University School of Medicine and as director for global exchange at Stanford’s Biodesign program, where he continues to play an advisory role.

Dr. Mairal also cofounded and served as executive vice president of Orbees Medical, a consulting company that provides strategic advice and emerging market–development services to the global health care industry. He held several positions at Johnson & Johnson, including director of research and development and marketing efforts for cardiology-related medical devices.

Dr. Mairal earned a PhD in chemical engineering from the University of Colorado at Boulder and an MBA from the University of California at Berkeley. He also holds an MS in chemical engineering from the Indian Institution of Technology in Mumbai. His work has been published in more than 20 publications, and he has been issued seven patents.

Helen McGuire

Director, Noncommunicable Diseases

Ms. McGuire leads a growing portfolio of projects focused on diabetes and cardiovascular disease and build close linkages with our longstanding work in women's cancers.

Ms. McGuire's 15-year career in noncommunicable diseases includes senior posts at the International Diabetes Federation (IDF) in Brussels and experience driving major projects in public health, clinical care, education, and system redesign.

Prior to joining PATH in 2013, Ms. McGuire served as acting director of policy and programs at the IDF, where she led strategy implementation for diabetes education and health systems in collaboration with national member associations and global leaders in diabetes. Other major achievements include negotiating and establishing an innovative diabetes education program in more than 100 countries and building the D-Net online diabetes network for health care professionals.

Ms. McGuire also served as the senior member of the research team for the recently completed 3C Study, which provided comprehensive understanding of the coverage, cost, and care of type 1 diabetes in China. This groundbreaking research is being used to shape Chinese government policy on type 1 diabetes.

Kathy Neuzil, MD, MPH

Dr. Neuzil directs PATH’s activities in vaccine access and delivery, which focus on developing and advancing strategies, technologies, and interventions that help move research achievements in immunization into routine use in the field. Since joining PATH in 2005, Dr. Neuzil has provided strategic leadership, direction, and technical guidance for a variety of vaccine projects and studies, including work on vaccines against rotavirus, HPV, Japanese encephalitis, and influenza.

Prior to joining PATH, Dr. Neuzil held academic positions at the University of Washington and Vanderbilt University, where she led research projects on a variety of viral and bacterial vaccines, including influenza, respiratory syncytial virus, pneumococcus, and varicella-zoster virus. She retains a clinical professorship in medicine and global health at the University of Washington and has contributed more than 100 scientific papers on vaccines and infectious diseases.

Dr. Neuzil has extensive experience in domestic and international policy, including membership on the Centers for Disease Control Advisory Committee on Immunization Practices and the Pandemic Influenza Task Force for the Infectious Disease Society of America. Dr. Neuzil has worked with the World Health Organization as a technical advisor on diarrheal diseases, member of the Strategic Advisory Group of Experts rotavirus vaccine working group, and member of the Global Advisory Committee on Vaccine Safety working group on the safety of vaccines in pregnancy.

Dr. Neuzil received her BS in zoology from the University of Maryland, her MD from Johns Hopkins University School of Medicine, and her MPH from Vanderbilt University. She received her training in internal medicine and infectious diseases at Vanderbilt University.

Julie Pulerwitz, ScD, ScM

Global Program Leader, HIV/AIDS and Tuberculosis

Dr. Pulerwitz directs PATH's work in HIV/AIDS and tuberculosis, as well as the AIDSTAR Project. She brings more than 15 years of experience in HIV/AIDS program development and implementation, HIV-related monitoring and evaluation and operations research, and social and behavioral sciences. She has particular expertise in behavior change communication, HIV prevention, male engagement in gender equity, stigma and discrimination, migration issues, and indicators development.

Prior to this position, Dr. Pulerwitz served as the research director for the Horizons Program, a global HIV/AIDS operations research program. Funded by PEPFAR, the ten-year program identified successful HIV prevention, care, and treatment strategies.

Dr. Pulerwitz has authored more than 20 articles in peer-reviewed journals and book chapters, as well as a variety of in-house publications. She regularly participates in technical advisory groups, reviews for scientific journals, and guest-lectures at institutions such as the Johns Hopkins School of Hygiene & Public Health.

Dr. Pulerwitz received her masters and doctoral degrees from the Harvard School of Public Health, as well as a graduate degree from the University of Buenos Aires School of Public Health. Dr. Pulerwitz has worked in multiple countries in Asia, Africa, and Latin America and the Caribbean, and she speaks Spanish and Portuguese.

Ponni Subbiah, MD, MPH

Global Program Leader, Drug Development (OneWorld Health)

Dr. Subbiah directs PATH’s drug development program, which seeks to discover, develop, and deliver safe, effective, and affordable treatments for neglected diseases in the developing world. Prior to joining PATH, Dr. Subbiah spent 15 years with Pfizer Inc., where her most recent position was vice president of global access within the Emerging Markets Business Unit. In that position, she led the company’s global access strategy and worked with a variety of public- and private-sector partners—including Grameen and the Clinton Foundation—to explore innovative approaches to expanding access to key medications and health services.

Other positions she held at Pfizer include vice president of global medical affairs for the Urology/Respiratory Group and vice president, US medical affairs, for the Arthritis, Pain, Metabolic, and Neuroscience Groups. In these positions she provided strategic direction for clinical research and medical management for a range of drugs. She also has provided leadership in interactions with regulatory authorities and served as a medical spokesperson for Pfizer for key media communications and public events.

Dr. Subbiah received her medical degree from Madras Medical College in India and her MPH from Johns Hopkins University in Baltimore, Maryland. She completed an internship and residencies at Howard University Hospital in Washington, DC, and the Mayo Graduate School of Medicine in Rochester, Minnesota. Before joining Pfizer, she worked as a neurologist in several facilities in Fresno, California.

While at Pfizer, Dr. Subbiah spent time as a Pfizer Global Health Fellow, teaching and providing patient care at Mulago Hospital in Kampala, Uganda. She also has volunteered in a range of settings, including working with HIV-positive individuals and AIDS orphans in Uganda. The cumulative result of these experiences has led Dr. Subbiah to develop a passion for improving access to medicines and health care for underserved populations in the developing world.

Dr. Subbiah received the Asian Women in Business Corporate Leadership award, Pfizer NY Site Change Agent award, and Pfizer W.E. Upjohn Award for Community Service.

Catharine Taylor, MSc Econ

Global Program Leader, Maternal and Child Health and Nutrition

Catharine Taylor directs PATH’s activities in maternal health, child health, and nutrition. Ms. Taylor has 25 years of experience in international and domestic sexual and reproductive health, with a focus on maternal/newborn health and programming for youth. Before joining PATH in 2008, she worked as the lead specialist for maternal health and as the program manager for the multisectoral program for HIV/AIDS in South Africa with HLSP. Previous to that, she served as an expert in civil society organizations for a large European Union–funded reproductive health program in Turkey, the Asia regional advisor for Plan International, and the technical training advisor for the Nepal Safe Motherhood Project, in addition to undertaking numerous program evaluation and strategic planning assignments.

Over the course of her career, Ms. Taylor has specialized in designing and implementing capacity-building approaches for nongovernmental organizations, human resources development, and health facilities and systems strengthening. She practiced and taught nursing and midwifery for more than a decade before moving into international health work, and she currently serves on the board of the White Ribbon Alliance for Safe Motherhood.

Ms. Taylor holds degrees from the College of Nursing and Midwifery in North Wales and an advanced diploma in midwifery from the Sheffield Polytechnic and Jessop Hospital for Women. She also holds an MS in economics from the Sir David Owen Population Centre at the University of Wales and has completed a graduate certificate program in global change and social innovation from Case Western Reserve University, Weatherhead School of Management.